H

Herantis Pharma Oyj
OMXH:HRTIS

Watchlist Manager
Herantis Pharma Oyj
OMXH:HRTIS
Watchlist
Price: 1.555 EUR -5.76% Market Closed
Market Cap: 31.3m EUR
Have any thoughts about
Herantis Pharma Oyj?
Write Note

Intrinsic Value

HRTIS's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one HRTIS stock under the Base Case scenario is 0.172 EUR. Compared to the current market price of 1.555 EUR, Herantis Pharma Oyj is Overvalued by 89%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HRTIS Intrinsic Value
0.172 EUR
Overvaluation 89%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Herantis Pharma Oyj

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
HRTIS
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for HRTIS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about HRTIS?
Bearish
Neutral
Bullish

Fundamental Analysis

1.555 EUR
-5.76%
-5.76%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Herantis Pharma Oyj
FI
Pharmaceuticals
Market Cap
31.3m EUR
IPO
Jun 11, 2014
Employees
-
Finland
Market Cap
31.3m EUR
Industry
Pharmaceuticals
IPO
Jun 11, 2014
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Herantis Pharma Oyj

Provide an overview of the primary business activities
of Herantis Pharma Oyj.

What unique competitive advantages
does Herantis Pharma Oyj hold over its rivals?

What risks and challenges
does Herantis Pharma Oyj face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Herantis Pharma Oyj.

Provide P/S
for Herantis Pharma Oyj.

Provide P/E
for Herantis Pharma Oyj.

Provide P/OCF
for Herantis Pharma Oyj.

Provide P/FCFE
for Herantis Pharma Oyj.

Provide P/B
for Herantis Pharma Oyj.

Provide EV/S
for Herantis Pharma Oyj.

Provide EV/GP
for Herantis Pharma Oyj.

Provide EV/EBITDA
for Herantis Pharma Oyj.

Provide EV/EBIT
for Herantis Pharma Oyj.

Provide EV/OCF
for Herantis Pharma Oyj.

Provide EV/FCFF
for Herantis Pharma Oyj.

Provide EV/IC
for Herantis Pharma Oyj.

Show me price targets
for Herantis Pharma Oyj made by professional analysts.

What are the Revenue projections
for Herantis Pharma Oyj?

How accurate were the past Revenue estimates
for Herantis Pharma Oyj?

What are the Net Income projections
for Herantis Pharma Oyj?

How accurate were the past Net Income estimates
for Herantis Pharma Oyj?

What are the EPS projections
for Herantis Pharma Oyj?

How accurate were the past EPS estimates
for Herantis Pharma Oyj?

What are the EBIT projections
for Herantis Pharma Oyj?

How accurate were the past EBIT estimates
for Herantis Pharma Oyj?

Compare the revenue forecasts
for Herantis Pharma Oyj with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Herantis Pharma Oyj and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Herantis Pharma Oyj against its competitors.

Analyze the profit margins
(gross, operating, and net) of Herantis Pharma Oyj compared to its peers.

Compare the P/E ratios
of Herantis Pharma Oyj against its peers.

Discuss the investment returns and shareholder value creation
comparing Herantis Pharma Oyj with its peers.

Analyze the financial leverage
of Herantis Pharma Oyj compared to its main competitors.

Show all profitability ratios
for Herantis Pharma Oyj.

Provide ROE
for Herantis Pharma Oyj.

Provide ROA
for Herantis Pharma Oyj.

Provide ROIC
for Herantis Pharma Oyj.

Provide ROCE
for Herantis Pharma Oyj.

Provide Gross Margin
for Herantis Pharma Oyj.

Provide Operating Margin
for Herantis Pharma Oyj.

Provide Net Margin
for Herantis Pharma Oyj.

Provide FCF Margin
for Herantis Pharma Oyj.

Show all solvency ratios
for Herantis Pharma Oyj.

Provide D/E Ratio
for Herantis Pharma Oyj.

Provide D/A Ratio
for Herantis Pharma Oyj.

Provide Interest Coverage Ratio
for Herantis Pharma Oyj.

Provide Altman Z-Score Ratio
for Herantis Pharma Oyj.

Provide Quick Ratio
for Herantis Pharma Oyj.

Provide Current Ratio
for Herantis Pharma Oyj.

Provide Cash Ratio
for Herantis Pharma Oyj.

What is the historical Revenue growth
over the last 5 years for Herantis Pharma Oyj?

What is the historical Net Income growth
over the last 5 years for Herantis Pharma Oyj?

What is the current Free Cash Flow
of Herantis Pharma Oyj?

Discuss the annual earnings per share (EPS)
trend over the past five years for Herantis Pharma Oyj.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Herantis Pharma Oyj

Current Assets 3.6m
Cash & Short-Term Investments 3.5m
Receivables 117k
Other Current Assets 42k
Current Liabilities 1.6m
Accounts Payable 784k
Accrued Liabilities 753k
Other Current Liabilities 46k
Non-Current Liabilities 25k
Long-Term Debt 25k
Efficiency

Earnings Waterfall
Herantis Pharma Oyj

Revenue
0 EUR
Operating Expenses
-193.6k EUR
Operating Income
-193.6k EUR
Other Expenses
-418.5k EUR
Net Income
-612.2k EUR

Free Cash Flow Analysis
Herantis Pharma Oyj

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

HRTIS Profitability Score
Profitability Due Diligence

Herantis Pharma Oyj's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
ROIC is Increasing
Exceptional ROIC
Negative Free Cash Flow
47/100
Profitability
Score

Herantis Pharma Oyj's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

HRTIS Solvency Score
Solvency Due Diligence

Herantis Pharma Oyj's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
67/100
Solvency
Score

Herantis Pharma Oyj's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HRTIS Price Targets Summary
Herantis Pharma Oyj

Wall Street analysts forecast HRTIS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HRTIS is 1.479 EUR with a low forecast of 0.707 EUR and a high forecast of 2.31 EUR.

Lowest
Price Target
0.707 EUR
55% Downside
Average
Price Target
1.479 EUR
5% Downside
Highest
Price Target
2.31 EUR
49% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HRTIS?

Click here to dive deeper.

Dividends

Herantis Pharma Oyj
does not pay dividends
Shareholder Yield

Current shareholder yield for HRTIS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one HRTIS stock?

The intrinsic value of one HRTIS stock under the Base Case scenario is 0.172 EUR.

Is HRTIS stock undervalued or overvalued?

Compared to the current market price of 1.555 EUR, Herantis Pharma Oyj is Overvalued by 89%.

Back to Top